Ito Shigenori, Nakasuka Kosuke, Morimoto Kotaro, Inomata Masahiko, Yoshida Takayuki, Tamai Nozomu, Suzuki Shin, Murakami Yoshimasa, Morino Akihiro, Shimizu Yoshiyuki, Sato Koichi
Division of Cardiology, East Medical Center, Higashi Municipal Hospital City of Nagoya, 1-2-23 Wakamizu-cho, Chikusa-ku, Nagoya-shi, Aichi, 464-8547, Japan.
J Invasive Cardiol. 2011 Feb;23(2):57-64.
Recent studies have shown that drug-eluting stents (DES) induce vascular endothelial dysfunction in both Cypher and Taxus stents. These studies evaluated coronary vasomotion in the peristent coronary segment for 1 lesion with 1 DES. The angiographic and clinical characteristics of real-world patients with coronary spasm following DES implantation have not been well documented.
All patients at our hospital who underwent coronary angiography at follow up after DES deployment (Cypher and Taxus stents) between July 2007 and March 2009 were included. We performed an acetylcholine (ACh) provocation test for diagnosing coronary vasospasm in 3 vessels, except in patients with significant stenosis or contraindications to ACh administration. ACh provocation test was positive in 36/55 of the coronary arteries (65.4%) and in 30/42 of the patients with DES (71.4%). There was no difference in the positive rate between patients with and without symptoms. A total of 13/20 asymptomatic patients (65.0%) also showed positive results. In patients with positive results in the ACh provocation test, vasoconstriction at segments distal to the stent was exaggerated compared with corresponding segments in non-stented vessels (0.46 ± 0.27 versus 0.31 ± 0.20, respectively; p = 0.008). Vessels with positive results had a longer stent length compared with those with negative results (31.6 ± 13.6 mm versus 24.2 ± 11.2 mm, respectively; p = 0.049).
Coronary vasoconstriction was exaggerated at distal segments in DES-implanted vessels compared to non-stented vessel segments and stent length was longer in the ACh provocation test positive group.
近期研究表明,药物洗脱支架(DES)在Cypher和Taxus支架中均会引发血管内皮功能障碍。这些研究评估了1个DES治疗1处病变的持续性冠状动脉节段中的冠状动脉运动。DES植入后发生冠状动脉痉挛的真实世界患者的血管造影和临床特征尚未得到充分记录。
纳入我院2007年7月至2009年3月间接受DES(Cypher和Taxus支架)植入并在随访时接受冠状动脉造影的所有患者。除有严重狭窄或乙酰胆碱给药禁忌证的患者外,我们对3支血管进行了乙酰胆碱(ACh)激发试验以诊断冠状动脉痉挛。在55支冠状动脉中的36支(65.4%)以及42例DES患者中的30例(71.4%)中,ACh激发试验呈阳性。有症状和无症状患者的阳性率无差异。共有13/20例无症状患者(65.0%)也呈阳性结果。在ACh激发试验呈阳性的患者中,支架远端节段的血管收缩与未植入支架血管的相应节段相比更为明显(分别为0.46±0.27与0.31±0.20;p = 0.008)。试验结果呈阳性的血管与呈阴性的血管相比,支架长度更长(分别为31.6±13.6 mm与24.2±11.2 mm;p = 0.049)。
与未植入支架的血管节段相比,DES植入血管的远端节段冠状动脉收缩更为明显,且在ACh激发试验阳性组中支架长度更长。